From heart to mind: The urotensin II system and its evolving neurophysiological role

FEBS Journal

Volumn 272, Issue 22, 2005, Pages 5694-5702

  Nothacker, Hans Peter ^a   Clark, Stewart ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Acetylcholine; Laterodorsal tegmental nucleus; Pedunculopontine tegmental nucleus; REM sleep; Urotensin II; Urotensin II related peptide; Urotensin receptors

Indexed keywords

ADRENALIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE RECEPTOR; OREXIN; PHOSPHOLIPASE C; PROTEIN C FOS; PROTEIN KINASE C; SOMATOSTATIN RECEPTOR; UROTENSIN II;

AMINO TERMINAL SEQUENCE; ANTERIOR HYPOTHALAMUS; ARCUATE NUCLEUS; BRAIN BLOOD FLOW; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHOLINERGIC NERVE CELL; GENE STRUCTURE; GENETIC CONSERVATION; HUMAN; HYPERTENSION; HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; LOCOMOTION; MOLECULAR MECHANICS; NEUROPHYSIOLOGY; NONHUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REM SLEEP; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SHORT SURVEY; SLEEP; SLOW WAVE SLEEP; TACHYCARDIA; TEGMENTUM; WAKEFULNESS;

ACETYLCHOLINE; ANIMALS; AROUSAL; HEART; MODELS, NEUROLOGICAL; NEUROPEPTIDES; NEUROPHYSIOLOGY; PONS; PROTEIN ISOFORMS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PRESYNAPTIC; SLEEP, REM; TEGMENTUM MESENCEPHALI; UROTENSINS;

MAMMALIA;

EID: 28044465622     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04983.x     Document Type: Short Survey

References (53)

1. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS & Bern HA (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77, 5021-5024.
2. Conlon JM (2000) Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research. Regul Pept 93, 3-12.
3. Itoh H, Itoh Y, Rivier J & Lederis K (1987) Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am J Physiol 252, R361-R366.
4. Gibson A, Wallace P & Bern HA (1986) Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen Comp Endocrinol 64, 435-439.
5. Coulouarn Y, Jegou S, Tostivint H, Vaudry H & Lihrmann I (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457, 28-32.
6. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA & Vaudry H (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95, 15803-15808.
7. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, et al (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401, 282-286.
8. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, O'Dowd B, Duckles SP & Civelli O (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1, 383-385.
9. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, Kikuchi K, Shintani Y, Kurokawa T, Onda H, Nishimura O & Fujino M (1999) Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265, 123-129.
10. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL Jr, Davidoff M, Wang R, Austin CP, McDonald TP, Bai C, George SR, Evans JF & Caskey CT (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266, 174-178.
11. Marchese A, Heiber M, Nguyen T, Heng HH, Saldivia VR, Cheng R, Murphy PM, Tsui LC, Shi X, Gregor P et al (1995) Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29, 335-344.
12. Tal M, Ammar DA, Karpuj M, Krizhanovsky V, Naim M & Thompson DA (1995) A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem Biophys Res Commun 209, 752-759.
13. Kemp W, Roberts S & Krum H (2005) Urotensin II: a vascular mediator in health and disease. Curr Vasc Pharmacol 3, 159-168.
14. Russell FD (2004) Emerging roles of urotensin-II in cardiovascular disease. Pharmacol Ther 103, 223-243.
15. Thanassoulis G, Huyhn T & Giaid A (2004) Urotensin II and cardiovascular diseases. Peptides 25, 1789-1794.
16. Douglas SA, Dhanak D & Johns DG (2004) From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci 25, 76-85.
17. Sugo T, Murakami Y, Shimomura Y, Harada M, Abe M, Ishibashi Y, Kitada C, Miyajima N, Suzuki N, Mori M & Fujino M (2003) Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310, 860-868.
18. McMaster D, Kobayashi Y, Rivier J & Lederis K (1986) Characterization of the biologically and antigenically important regions of urotensin II. Proc West Pharmacol Soc 29, 205-208.
19. Coy DH, Rossowski WJ, Cheng BL & Taylor JE (2002) Structural requirements at the N-terminus of urotensin II octapeptides. Peptides 23, 2259-2264.
20. Chatenet D, Dubessy C, Leprince J, Boularan C, Carlier L, Segalas-Milazzo I, Guilhaudis L, Oulyadi H, Davoust D, Scalbert E et al (2004) Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25, 1819-1830.
21. Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Muller C, et al (2004) Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4- hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System. J Pharmacol Exp Ther 311, 204-212.
22. Pelletier G, Lihrmann I, Dubessy C, Luu-The V, Vaudry H & Labrie F (2005) Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132, 689-696.
23. Schluter H, Jankowski J, Rykl J, Thiemann J, Belgardt S, Zidek W, Wittmann B & Pohl T (2003) Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system. Anal Bioanal Chem 377, 1102-1107.
24. Rossowski WJ, Cheng BL, Taylor JE, Datta R & Coy DH (2002) Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 438, 159-170.
25. Saetrum OO, Nothacker H, Ehlert FJ & Krause DN (2000) Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol 406, 265-271.
26. Onan D, Pipolo L, Yang E, Hannan RD & Thomas WG (2004) Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol 18, 2344-2354.
27. Lin Y, Matsumura K, Tsuchihashi T, Fukuhara M, Fujii K & Iida M (2004) Role of ERK and Rho kinase pathways in central pressor action of urotensin II. J Hypertens 22, 983-988.
28. Filipeanu CM, Brailoiu E, Le Dun S & Dun NJ (2002) Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J Neurochem 83, 879-884.
29. Chartrel N, Leprince J, Dujardin C, Chatenet D, Tollemer H, Baroncini M, Balment RJ, Beauvillain JC & Vaudry H (2004) Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 91, 110-118.
30. Dun SL, Brailoiu GC, Yang J, Chang JK & Dun NJ (2001) Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 305, 9-12.
31. Gartlon J, Parker F, Harrison DC, Douglas SA, Ashmeade TE, Riley GJ, Hughes ZA, Taylor SG, Munton RP, Hagan JJ, et al (2001) Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) 155, 426-433.
32. Clark SD, Nothacker HP, Wang Z, Saito Y, Leslie FM & Civelli O (2001) The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res 923, 120-127.
33. Brailoiu E, Brailoiu GC, Miyamoto MD & Dun NJ (2003) The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br J Pharmacol 138, 1580-1588.
34. Lu Y, Zou CJ, Huang DW & Tang CS (2002) Cardiovascular effects of urotensin II in different brain areas. Peptides 23, 1631-1635.
35. Lin Y, Tsuchihashi T, Matsumura K, Fukuhara M, Ohya Y, Fujii K & Iida M (2003) Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens Res 26, 839-845.
36. Lin Y, Tsuchihashi T, Matsumura K, Abe I & Iida M (2003) Central cardiovascular action of urotensin II in conscious rats. J Hypertens 21, 159-165.
37. Vale W, Spiess J, Rivier C & Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
38. Saffran M, Schally AV & Benfey BG (1955) Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor. Endocrinology 57, 439-444.
39. Guillemin R & Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 57, 599-607.
40. Watson AM, Lambert GW, Smith KJ & May CN (2003) Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42, 373-379.
41. Gartlon JE, Ashmeade T, Duxon M, Hagan JJ & Jones DN (2004) Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain. Eur J Pharmacol 493, 95-98.
42. Koob GF & Heinrichs SC (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848, 141-152.
43. Matsumoto Y, Abe M, Watanabe T, Adachi Y, Yano T, Takahashi H, Sugo T, Mori M, Kitada C, Kurokawa T & Fujino M (2004) Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents. Neurosci Lett 358, 99-102.
44. Huitron-Resendiz S, Kristensen MP, Sanchez-Alavez M, Clark SD, Grupke SL, Tyler C, Suzuki C, Nothacker HP, Civelli O et al (2005) Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neuroscience 25, 5465-5474.
45. Behm DJ, Harrison SM, Ao Z, Maniscalco K, Pickering SJ, Grau EV, Woods TN, Coatney RW, Doe CP, Willette RN et al (2003) Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice. Br J Pharmacol 139, 464-472.
46. Webster HH & Jones BE (1988) Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states. Brain Res 458, 285-302.
47. George R, Haslett WL & Jenden DJ (1964) A cholinergic mechanism in the brainstem reticular formation: induction of paradoxical sleep. Int J Neuropharmacol 72, 541-552.
48. Baghdoyan HA, Monaco AP, Rodrigo-Angulo ML, Assens F, McCarley RW & Hobson JA (1984) Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther 231, 173-180.
49. Quattrochi JJ, Mamelak AN, Madison RD, Macklis JD & Hobson JA (1989) Mapping neuronal inputs to REM sleep induction sites with carbachol-fluorescent microspheres. Science 245, 984-986.
50. Bourgin P, Escourrou P, Gaultier C & Adrien J (1995) Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport 6, 532-536.
51. Steriade M & McCarley R (1990) Brainstem Control of Wakefulness and Sleep. Plenum, New York.
52. Xi MC, Morales FR & Chase MH (2001) Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901, 259-264.
53. Mori M & Fujino M (2004) Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25, 1815-1818.